Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Biochemical and Biophysical Research Communications|January 17, 2020
The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancerYu Ishizuya, Motohide Uemura, Ryohei Narumi, et al.
Cancer Science|January 25, 2020
MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinomaCong Wang, Motohide Uemura, Eisuke Tomiyama, et al.
International Journal of Clinical Oncology|January 20, 2021
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective studyTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
NPJ Precision Oncology|November 18, 2025
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen projectTakahiro Osawa, Nobuaki Matsubara, Taigo Kato, et al.
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 20, 2022
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinomaYoko Koh, Kosuke Nakano, Kotoe Katayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2026
Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With EnzalutamideTomohiro Kanaki, Koji Hatano, Toshiki Oka, et al.
Anticancer Research|November 4, 2021
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell CarcinomaTaigo Kato, Akira Nagahara, Norihiko Kawamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.
Pageof 18